DK0389995T3 - Isoquinolinderivater til behandling af glaukom eller okular hypertension - Google Patents

Isoquinolinderivater til behandling af glaukom eller okular hypertension

Info

Publication number
DK0389995T3
DK0389995T3 DK90105606.9T DK90105606T DK0389995T3 DK 0389995 T3 DK0389995 T3 DK 0389995T3 DK 90105606 T DK90105606 T DK 90105606T DK 0389995 T3 DK0389995 T3 DK 0389995T3
Authority
DK
Denmark
Prior art keywords
glaucoma
treatment
ocular hypertension
isoquinoline derivatives
isoquinoline
Prior art date
Application number
DK90105606.9T
Other languages
English (en)
Inventor
Toyohiro Tadokoro
Kiyoshi Sato
Shigeki Hatakeyama
Shigeo Kawase
Masao Ueno
Original Assignee
Nisshin Flour Milling Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7386689A external-priority patent/JPH02255618A/ja
Priority claimed from JP24230389A external-priority patent/JPH03106816A/ja
Application filed by Nisshin Flour Milling Co filed Critical Nisshin Flour Milling Co
Application granted granted Critical
Publication of DK0389995T3 publication Critical patent/DK0389995T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK90105606.9T 1989-03-28 1990-03-24 Isoquinolinderivater til behandling af glaukom eller okular hypertension DK0389995T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7386689A JPH02255618A (ja) 1989-03-28 1989-03-28 緑内障治療剤
JP24230389A JPH03106816A (ja) 1989-09-20 1989-09-20 緑内障治療用点眼剤

Publications (1)

Publication Number Publication Date
DK0389995T3 true DK0389995T3 (da) 1995-07-03

Family

ID=26415010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90105606.9T DK0389995T3 (da) 1989-03-28 1990-03-24 Isoquinolinderivater til behandling af glaukom eller okular hypertension

Country Status (6)

Country Link
US (1) US5061714A (da)
EP (1) EP0389995B1 (da)
CA (1) CA2013167A1 (da)
DE (1) DE69019774T2 (da)
DK (1) DK0389995T3 (da)
ES (1) ES2075082T3 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141051B2 (ja) * 1992-10-09 2001-03-05 日清製粉株式会社 抗動脈硬化剤
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
WO2006047466A2 (en) * 2004-10-21 2006-05-04 Duke University Ophthamological drugs
CA2503099A1 (en) * 2005-04-18 2006-10-18 Kabushiki Kaisha Yakult Honsha Pharmaceutical compositions containing camptothecins
US7470787B2 (en) 2005-07-11 2008-12-30 Aerie Pharmaceuticals, Inc. Isoquinoline compounds
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
EP2526948A1 (en) 2006-09-20 2012-11-28 Aerie Pharmaceuticals, Inc. RHO kinase inhibitors
UY30639A1 (es) 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
WO2009034326A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
AU2008313467B2 (en) 2007-10-17 2013-08-29 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-1-carbonyl) -4 -fluoro-benzyl] -2H-phthalazin-1-one
US8455514B2 (en) 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
CN102238945B (zh) 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514
CA2929545C (en) 2009-05-01 2019-04-09 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
TWI499418B (zh) 2009-05-21 2015-09-11 Nerviano Medical Sciences Srl 異喹啉－１（２ｈ）－酮衍生物
EP4335507A3 (en) 2013-03-15 2024-06-05 Aerie Pharmaceuticals, Inc. Combination therapy
AU2015414743B2 (en) 2015-11-17 2019-07-18 Alcon Inc. Process for the preparation of kinase inhibitors and intermediates thereof
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
MX2019011784A (es) 2017-03-31 2019-11-18 Aerie Pharmaceuticals Inc Compuestos de aril ciclopropil-amino-isoquinolinil amida.
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
WO2023241652A1 (zh) * 2022-06-16 2023-12-21 广州润尔眼科生物科技有限公司 一种药物组合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
GB1590629A (en) * 1976-09-23 1981-06-03 Cam Gears Ltd Powerassisted gear system
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
JPS57212161A (en) * 1981-06-25 1982-12-27 Nisshin Flour Milling Co Ltd Isocarbostyril derivative
JPS59116269A (ja) * 1982-12-24 1984-07-05 Nisshin Flour Milling Co Ltd イソカルボスチリル誘導体
JPS60237070A (ja) * 1984-05-08 1985-11-25 Nisshin Flour Milling Co Ltd 光学活性イソカルボスチリル誘導体の製法
JPS6355512A (ja) * 1986-08-27 1988-03-10 Hitachi Ltd 微小物質撮像装置

Also Published As

Publication number Publication date
EP0389995A2 (en) 1990-10-03
DE69019774T2 (de) 1995-11-09
CA2013167A1 (en) 1990-09-28
US5061714A (en) 1991-10-29
DE69019774D1 (de) 1995-07-06
EP0389995A3 (en) 1991-10-30
EP0389995B1 (en) 1995-05-31
ES2075082T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
DK0389995T3 (da) Isoquinolinderivater til behandling af glaukom eller okular hypertension
DK176487A (da) Middel til behandling af inflammationer i oejet
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
DK404187D0 (da) Fremgangsmaade til fremstilling af thiazolderivater
DK230789D0 (da) Fremgangsmaade til fremstilling af cytidinderivater
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
DK250689A (da) Fremgangsmaade til fremstilling af napthalenderivater
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
DK674287A (da) Fremgangsmaade til fremstilling af optisk aktive dihydropyridinderivater
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
DK30489A (da) Fremgangsmaade til fremstilling af pyranderivater
NO921993L (no) Fremgangsmaate for efterbehandling av amfotaere eller zwitterioniske tensider
DK164988D0 (da) Fremgangsmaade til fremstilling af chromanderivater
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
DK0409321T3 (da) Fremgangsmåde til fremstilling af delta-lactoner
DK293589A (da) Fremgangsmaade til fremstiling af lactolderivater
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK599689D0 (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK732088D0 (da) Fremgangsmaade til fremstilling af 1,5-benzothiazepinderivater
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO904588D0 (no) Fremgangsmaate til fremstilling av diazinylpiperidin-derivater